Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tarmim Ava Baran is an Iranian biotechnology company specializing in the development and production of advanced wound care products. The company's portfolio includes bioactive dressings, collagen matrices, and hydrogels designed to treat chronic and acute wounds, including diabetic foot ulcers and severe burns. As a designated knowledge-based company, it focuses on translating regenerative medicine research into clinical applications to improve patient outcomes in wound management. Their products are primarily utilized in hospital settings and specialized wound clinics to accelerate tissue regeneration and prevent infection. The company leverages advanced biomaterials to provide cost-effective alternatives to traditional wound care therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tarmim Ava Baran Knowledge Based Company.